Innovative Eyewear Inc(LUCY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 4:00 PM ET (Korea 11/6 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.35 | Insider Own | 10.15% | Shs Outstand | 8.7M | Perf Week | -1.14% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | -8.53% | Shs Float | 7.8M | Perf Month | -9.98% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 8.62% | Short Float | 1.86% | Perf Quarter | 14.01% |
| Income | -0.01B | P/S | 2.1 | EPS this Y | - | Inst Trans | 11.16% | Short Ratio | 0.04 | Perf Half Y | -21.81% |
| Sales | 0.00B | P/B | 0.76 | EPS next 5Y | - | ROA | -79.21% | Short Interest | 0.15M | Perf YTD | -17.61% |
| Book/sh | 1.08 | P/C | 1.91 | EPS past 3/5Y | 50.36% 1.99% | ROE | -84.58% | 52W High | -59.36% ($2.02) | Perf Year | -48.04% |
| Cash/sh | 0.43 | P/FCF | - | Sales past 3/5Y | 59.19% 115.71% | ROIC | -111.35% | 52W Low | 26.31% ($0.65) | Perf 3Y | -90.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 58.34% | Gross Margin | 22.79% | Volatility(W/M) | 7.69% 6.52% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.02 | Sales Y/Y TTM | 72.5% | Oper. Margin | -249.03% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.1 | EPS Q/Q | 60.17% | Profit Margin | -225.28% | RSI (14) | 44.47 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.06 | Sales Q/Q | 74.46% | SMA20 | -2.34% ($0.84) | Beta | 2.74 | Target Price | $3 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/14 | SMA50 | -6.72% ($0.88) | Rel Volume | 0.03 | Prev Close | $0.84 |
| Employees | 13 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.73% 12.28% | SMA200 | -14.4% ($0.96) | Avg Volume(3M) | 3.46M | Price | $0.82 |
| IPO | 2022/8/15 | Option/Short | No/Yes | Trades | 437 | Volume | 119,985 | Change | -2.69% |
🕶️ Innovative Eyewear is a smart glasses specialist company headquartered in Miami, USA. A micro-cap wearable name, it sells voice assistant- and ChatGPT-integrated audio glasses and smart safety glasses for helmets under its own Lucyd brand as well as Nautica, Eddie Bauer, and Reebok license lines.
Over the past 1 year, on the lower side
59% below its 1-year high.
Traded less than usual. That is 3% of its average volume.
LUCY has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $210. Peers typically go for $246.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -90.3%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.6%.
Tap to view numbers
It ranks #51 of 51 in the industry
Based on market cap of $7M.
NXGL#47 Nexgel Inc $12M PER - 
FEMY#48 Femasys Inc $11M PER - 
CUPR#49 Cuprina Holdings (Cayman) Ltd $10M PER - 
RGNT#50 Regentis Biomaterials Ltd $8M PER - LUCY#51 Innovative Eyewear Inc $7M PER - 
FAQ
What kind of company is LUCY?
LUCY belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of LUCY?
The market cap of LUCY is approximately $7M, ranking 5,508 within its sector.
What is the 52-week high and low for LUCY?
LUCY has recorded a 52-week high of $2.02 and a low of $0.65.
